BackIambic Therapeutics Overview

Iambic Therapeutics Current Assets

Track Iambic Therapeutics's current assets ($320M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$315.93M

Peer trimmed avg / median

Loading

Iambic Therapeutics Current Assets History

Loading

Iambic Therapeutics vs. peers: Current Assets Comparison

Loading

Iambic Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Iambic Therapeutics (IAM) FAQ

The latest current assets for IAM is $320M as of September 2026. Investors often review this figure alongside Iambic Therapeutics's historical trend and sector peers before judging valuation or financial health.

A current assets figure of $320M for IAM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IAM's current assets ($320M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers